123 related articles for article (PubMed ID: 8892583)
1. Apoptosis in renal cell carcinoma: detection by in situ end-labeling of fragmented DNA and correlation with other prognostic factors.
Todd D; Yang G; Brown RW; Cao J; D'Agati V; Thompson TS; Truong LD
Hum Pathol; 1996 Oct; 27(10):1012-7. PubMed ID: 8892583
[TBL] [Abstract][Full Text] [Related]
2. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma.
Gelb AB; Sudilovsky D; Wu CD; Weiss LM; Medeiros LJ
Cancer; 1997 Nov; 80(9):1768-75. PubMed ID: 9351546
[TBL] [Abstract][Full Text] [Related]
3. Proliferating cell nuclear antigen and epidermal growth factor receptor (EGFr) status in renal cell carcinoma patients with polysomy of chromosome 7.
Amare Kadam PS; Varghese C; Bharde SH; Narasimhamoorthy NK; Desai S; Advani SH; Havaldar R; Kulkarni JN
Cancer Genet Cytogenet; 2001 Mar; 125(2):139-46. PubMed ID: 11369057
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of nuclear DNA content and proliferative activity in renal cell carcinomas. A clinicopathologic study of 58 patients using mitotic count, MIB-1 staining, and DNA cytophotometry.
Jochum W; Schröder S; al-Taha R; August C; Gross AJ; Berger J; Padberg BC
Cancer; 1996 Feb; 77(3):514-21. PubMed ID: 8630959
[TBL] [Abstract][Full Text] [Related]
5. DNA content and the proliferation marker Ki-67 as prognostic indicators in renal cell carcinoma.
Papadopoulos I; Weichert-Jacobsen K; Sprenger E; Wacker HH
Urol Int; 1994; 53(4):181-5. PubMed ID: 7855936
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
[TBL] [Abstract][Full Text] [Related]
7. Improving accuracy in the grading of renal cell carcinoma by combining the quantitative description of chromatin pattern with the quantitative determination of cell kinetic parameters.
François C; Moreno C; Teitelbaum J; Bigras G; Salmon I; Danguy A; Brugal G; van Velthoven R; Kiss R; Decaestecker C
Cytometry; 2000 Feb; 42(1):18-26. PubMed ID: 10679739
[TBL] [Abstract][Full Text] [Related]
8. Cell proliferation and apoptosis with BCL-2 expression in renal cell carcinoma.
Zhang X; Takenaka I
Urology; 2000 Sep; 56(3):510-5. PubMed ID: 10962335
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal gains and losses detected by comparative genomic hybridization and proliferation activity in renal cell carcinoma.
Kallio JP; Mahlamäki EH; Helin H; Karhu R; Kellokumpu-Lehtinen P; Tammela TL
Scand J Urol Nephrol; 2004; 38(3):225-30. PubMed ID: 15204376
[TBL] [Abstract][Full Text] [Related]
10. Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome.
Delahunt B; Bethwaite PB; Thornton A; Ribas JL
Cancer; 1995 Jun; 75(11):2714-9. PubMed ID: 7743475
[TBL] [Abstract][Full Text] [Related]
11. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
[TBL] [Abstract][Full Text] [Related]
12. Incidence of apoptosis, cell proliferation and P53 expression in renal cell carcinomas.
Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
Anticancer Res; 1997; 17(2A):1155-62. PubMed ID: 9137464
[TBL] [Abstract][Full Text] [Related]
13. Significance of conventional and new prognostic factors for locally confined renal cell carcinoma.
Hofmockel G; Tsatalpas P; Müller H; Dämmrich J; Poot M; Maurer-Schultze B; Müller-Hermelink HK; Frohmüller HG; Bassukas ID
Cancer; 1995 Jul; 76(2):296-306. PubMed ID: 8625106
[TBL] [Abstract][Full Text] [Related]
14. Expression of PTEN in renal cell carcinoma and its relation to tumor behavior and growth.
Shin Lee J; Seok Kim H; Bok Kim Y; Cheol Lee M; Soo Park C
J Surg Oncol; 2003 Nov; 84(3):166-72. PubMed ID: 14598361
[TBL] [Abstract][Full Text] [Related]
15. Biologic behavior of and p53 overexpression in multifocal renal cell carcinoma of clear cell type: an immunohistochemical study correlating grading, staging, and proliferation markers.
Haitel A; Wiener HG; Blaschitz U; Marberger M; Susani M
Cancer; 1999 Apr; 85(7):1593-8. PubMed ID: 10193951
[TBL] [Abstract][Full Text] [Related]
16. The MIB-1 tumor proliferation index in adult renal epithelial tumors with granular cytoplasm: biologic implications and differential diagnostic potential.
Tickoo SK; Amin MB; Linden MD; Zarbo RJ
Mod Pathol; 1998 Nov; 11(11):1115-21. PubMed ID: 9831210
[TBL] [Abstract][Full Text] [Related]
17. Cell proliferation, apoptosis, angiogenesis and growth rate of incidentally found renal cell carcinoma.
Oda T; Takahashi A; Miyao N; Yanase M; Masumori N; Itoh N; Sato MA; Kon S; Tsukamoto T
Int J Urol; 2003 Jan; 10(1):13-8. PubMed ID: 12534920
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
[TBL] [Abstract][Full Text] [Related]
19. The extent of proliferative and apoptotic activity in intraductal and invasive ductal breast carcinomas detected by Ki-67 labeling and terminal deoxynucleotidyl transferase-mediated digoxigenin-11-dUTP nick end labeling.
Shen KL; Harn HJ; Ho LI; Yu CP; Chiu SC; Lee WH
Cancer; 1998 Jun; 82(12):2373-81. PubMed ID: 9635530
[TBL] [Abstract][Full Text] [Related]
20. Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma.
Migita T; Oda Y; Naito S; Tsuneyoshi M
Cancer; 2002 Feb; 94(4):973-9. PubMed ID: 11920465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
